← Open Payments lookup

KIARA NIX: Open Payments

NPI 1245005446 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,395 in 79 payments from 10 companies in 2025. Trend: 2023 $31 · 2024 $820 · 2025 $1,395

Food & beverage: $1,395
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$275
Vanda Pharmaceuticals Inc.13$244
Alkermes, Inc.12$222
Neurocrine BioSciences, Inc.10$222
Otsuka America Pharmaceutical, Inc.12$175
ABBVIE INC.11$135
E.R. Squibb & Sons, L.L.C.3$47
Takeda Pharmaceuticals U.S.A., Inc.2$31
Teva Pharmaceuticals USA, Inc.2$29
Supernus Pharmaceuticals, Inc.1$15

Products named: CAPLYTA, FANAPT, INGREZZA, ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI.

Industry payments across AL — which companies pay providers there.